Engineered enzyme reduces AGE damage in human tissue samples
A proof-of-concept study reports that an engineered enzyme removed AGEs, advanced glycation end products, from human tissue samples, including tissue from a 75-year-old donor.
Source: Engineered enzyme reduces AGE damage in aged human tissue samples (x.com). Summary written with AI from the source and reviewed by rules; read the original.
What the research shows
A proof-of-concept study reports that an engineered enzyme was able to remove advanced glycation end products, known as AGEs, from human tissue samples. The samples included tissue from a donor aged 75. The removal described by the study was achieved in the laboratory, using tissue taken from the body, not in living people.
AGEs form when sugars react with proteins and accumulate in long-lived proteins such as collagen, which is found in skin, blood vessels and other tissues. For this reason, researchers study tools that reduce these products as a question linked to the aging of tissues. The text also notes that the claim that aging is solvable is the author's opinion, not a conclusion shown by the study.
What it means
The finding suggests it may be possible, in principle, to remove AGEs from human tissue in the laboratory. It is not yet known whether this enzyme would work inside the body, whether it would be safe, or whether it would reduce damage or improve health in people.
How to read it with care
A laboratory result like this does not replace a medical consultation. Anyone considering changes to diet, supplements or treatment should talk to a doctor or another qualified health professional.